Compare VREX & MOBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VREX | MOBI |
|---|---|---|
| Founded | 2016 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 447.2M | 383.0M |
| IPO Year | 2016 | 2026 |
| Metric | VREX | MOBI |
|---|---|---|
| Price | $18.50 | $9.02 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $16.67 | N/A |
| AVG Volume (30 Days) | ★ 634.2K | 194.4K |
| Earning Date | 05-07-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.23 | N/A |
| Revenue | ★ $811,000,000.00 | N/A |
| Revenue This Year | $5.35 | N/A |
| Revenue Next Year | $3.88 | N/A |
| P/E Ratio | $80.30 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $9.09 | $8.45 |
| 52 Week High | $18.63 | $15.19 |
| Indicator | VREX | MOBI |
|---|---|---|
| Relative Strength Index (RSI) | 81.02 | 35.34 |
| Support Level | $12.00 | N/A |
| Resistance Level | $18.63 | $11.55 |
| Average True Range (ATR) | 0.05 | 0.75 |
| MACD | -0.19 | -0.17 |
| Stochastic Oscillator | 50.00 | 17.82 |
Varex Imaging Corp Designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, detectors, ionization chambers, high-voltage connectors, software, collimators, generators, exposure control devices, and heat exchangers.. The company operates through two segments: Medical, the key revenue driver, providing X-ray imaging components and accessories for healthcare applications, and Industrial, which provides Linatron X-ray accelerators, X-ray tubes, flat panel detectors, high-voltage connectors, and coolers for non-medical use. Geographically, it generates the majority of its revenue from Europe, the Middle East, and Africa (EMEA), with the rest coming from the Americas and Asia Pacific.
Mobia Medical Inc is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. The company develops, markets and sells devices for the treatment of medical conditions. Its flagship device is the Vivistim Paired Vagus Nerve Stimulation system, which is used to support motor function rehabilitation in patients with chronic ischemic stroke. The company generates all of its revenue from the sale of the Vivistim System to customers, mainly primary and comprehensive stroke centers, in the United States.